Evidence map›Paper›PMID 36357408›Full record

ArticleScientific reports2022

Body fat percentage is independently and inversely associated with serum antibody responses to SARS-CoV-2 mRNA vaccines.

Jeremy B Ducharme, Zachary J McKenna, Zachary J Fennel, Roberto C Nava, Christine M Mermier, Michael R Deyhle

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.1field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Jeremy B DucharmeDepartment of Health, Exercise and Sports Sciences, University of New Mexico, Albuquerque, NM, USA.
Zachary J McKennaDepartment of Health, Exercise and Sports Sciences, University of New Mexico, Albuquerque, NM, USA.
Zachary J FennelDepartment of Health, Exercise and Sports Sciences, University of New Mexico, Albuquerque, NM, USA.
Roberto C NavaDepartment of Health, Exercise and Sports Sciences, University of New Mexico, Albuquerque, NM, USA.
Christine M MermierDepartment of Health, Exercise and Sports Sciences, University of New Mexico, Albuquerque, NM, USA.
Michael R DeyhleDepartment of Health, Exercise and Sports Sciences, University of New Mexico, Albuquerque, NM, USA. mdeyhle@unm.edu.
University of New Mexico · USThe University of Texas Southwestern Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vaccination is widely considered the most effective preventative strategy to protect against severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection. An individual's exercise habits, and physical fitness have been shown to impact the immune response following vaccination using traditional vaccine platforms, but their effects are not well characterized following administration of newer vaccination technology (mRNA vaccines). We investigated these effects on the magnitude of antibody responses following SARS-CoV-2 mRNA vaccination while accounting for known covariates (age, sex, time since vaccination, and the type of vaccine administered). Adults of varying fitness levels (18-65 years; N = 50) who had received either the Moderna or Pfizer SARS-CoV-2 mRNA vaccine between 2 weeks and 6 months prior, completed health history and physical activity questionnaires, had their blood drawn, body composition, cardiorespiratory fitness, and strength assessed. Multiple linear regressions assessed the effect of percent body fat, hand grip strength, cardiorespiratory fitness, and physical activity levels on the magnitude of receptor binding domain protein (RBD) and spike protein subunit 1 (S1) and 2 (S2) while accounting for known covariates. Body fat percentage was inversely associated with the magnitude of S1 (p = 0.006, β = - 366.56), RBD (p = 0.003, β = - 249.30), and S2 (p = 0.106, β = - 190.08) antibodies present in the serum following SARS-CoV-2 mRNA vaccination. Given the increasing number of infections, variants, and the known waning effects of vaccination, future mRNA vaccinations such as boosters are encouraged to sustain immunity; reducing excess body fat may improve the efficacy of these vaccinations.

Indexed as

COVID-19Viral VaccinesAdipose TissueAntibodies, ViralAntibody FormationCOVID-19 VaccinesHand StrengthHumansmRNA VaccinesRNA, MessengerSARS-CoV-2VaccinationAntibodies, ViralCOVID-19 VaccinesmRNA VaccinesRNA, MessengerViral Vaccines

Identifiers

PMID36357408
PMCPMC9648460
OpenAlexW4308885885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.